Singular Genomics Systems, Inc.·4

Sep 15, 7:03 PM ET

Ropp Sam 4

4 · Singular Genomics Systems, Inc. · Filed Sep 15, 2023

Insider Transaction Report

Form 4
Period: 2023-09-15
Ropp Sam
Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-15+4,1878,375 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-09-154,18758,625 total
    Common Stock (4,187 underlying)
Footnotes (3)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The RSUs vest in 16 equal quarterly installments measured from March 15, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION